The effect of varying remifentanil infusion rates on target controlled infusion propofol concentrations necessary to maintain anaesthesia as assessed by bi-spectral index

Phase 4

Completed

• Conditions: Anaesthesia; Anaesthesiology - Anaesthetics

• Registration Number: ACTRN12605000269639
• Lead Sponsor: Dr Lars Wang

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Surgery under general anaesthesia.

Exclusion Criteria

Pregnant and breastfeeding women, severe ischaemic heart disease, severe hypovolaemia, allergy to propofol or egg, emergency surgery, current opioid, benzodiazepine or high alcohol use.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dose of remifentanil and propofol required to maintain bi-spectral index < 50[30 minutes]

Secondary Outcome Measures

Name	Time	Method
IL[nil]